Indication
Stage IIIB Uterine Corpus Cancer AJCC v7
2 clinical trials
3 products
3 drugs
Clinical trial
A Phase II Study With a Limited Safety Lead-In of Enzalutamide in Combination With Carboplatin and Paclitaxel in Advanced Stage or Recurrent Endometrioid Endometrial CancerStatus: Completed, Estimated PCD: 2023-09-27
Drug
AN0025Product
EnzalutamideDrug
TiragolumabClinical trial
A Three Arm Randomized Phase II Study of Paclitaxel/Carboplatin/Bevacizumab (NSC #704865), Paclitaxel/Carboplatin/Temsirolimus (NSC #683864) and Ixabepilone (NSC #710428)/Carboplatin/Bevacizumab as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial CancerStatus: Active (not recruiting), Estimated PCD: 2015-01-31
Drug
AtezolizumabProduct
IxabepiloneProduct
Temsirolimus